Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kyverna Therapeutics Inc KYTX

Healthcare Biotechnology
Kyverna Therapeutics, Inc. is a patient-centered, clinical-stage biopharmaceutical company. The Company is focused on developing cell therapies for patients suffering from autoimmune diseases. The Company's lead program, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor (CAR). It intends to develop KYV-101 in two areas of autoimmune... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KYTX)

Kyverna Therapeutics Inc And KYTX Stock Holders Are Invited To Join A Securities Fraud Probe Conducted By The Schall Law Firm

Accesswire 20 hours ago

Kyverna Therapeutics Inc And KYTX Shareholders Are Invited To Be Involved In A Securities Fraud Probe Conducted By The Schall Law Firm

Accesswire 1 day ago

The Schall Law Firm Is Undertaking A Securities Fraud Probe Into Kyverna Therapeutics Inc And Encourages KYTX Shareholders To Join

Accesswire 2 days ago

Kyverna Therapeutics Inc And KYTX Stock Owners Are Encouraged To Participate In A Securities Fraud Investigation Led By The Schall Law Firm

Accesswire 3 days ago

The Schall Law Firm Is Conducting A Securities Fraud Investigation Into Kyverna Therapeutics Inc And Invites KYTX Shareholders To Participate

Accesswire 4 days ago

Kyverna Therapeutics Inc And KYTX Shareholders Are Invited To Be Involved In A Securities Fraud Probe Conducted By The Schall Law Firm

Accesswire 5 days ago

KYTX Shareholders Have The Opportunity To Participate In The Securities Fraud Investigation Of Kyverna Therapeutics Inc Led By The Schall Law Firm

Accesswire 6 days ago

The Schall Law Firm Is Conducting A Securities Fraud Probe Into Kyverna Therapeutics Inc And KYTX Shareholders Are Invited To Be Involved

Accesswire 7 days ago

KYTX Shareholders Can Join The Securities Fraud Investigation Of Kyverna Therapeutics Inc Conducted By The Schall Law Firm

Accesswire 8 days ago
View More News ››

Opinion & Analysis (NDAQ:KYTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KYTX)

Be the first to post on this bullboard.

Anfield Energy Inc

Anfield Energy Inc

Anfield Energy Inc. is a Canada-based uranium and vanadium development and near-term production company. A key asset in the ...
View More »